Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
ACTIVE_NOT_RECRUITING
Status
Conditions
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Myeloid Sarcoma
- Chronic Myeloid Leukemia (CML)
- Juvenile Myelomonocytic Leukemia (JMML)
- Myelodysplastic Syndrome (MDS)
- Non-Hodgkin Lymphoma (NHL)
Interventions
- DRUG: Anti-thymocyte globulin (rabbit)
- DRUG: Blinatumomab
- DRUG: Cyclophosphamide
- DRUG: Fludarabine
- DRUG: G-CSF
- DRUG: Melphalan
- DRUG: Mesna
- DRUG: Rituximab
- DRUG: Tacrolimus
- DRUG: Thiotepa
- BIOLOGICAL: HPC,A Infusion
- DEVICE: CliniMACS
- DRUG: Sirolimus
Sponsor
St. Jude Children's Research Hospital